ClinicalTrials.gg
CompletedNCT02787135CBTd-EUpdated Mar 5, 2020

Efficacy and Mechanisms of Change of an Emotion-oriented Version of Cognitive-behavioral Therapy for Psychosis

An interventional study of emotion-oriented Cognitive Behavior Therapy in Schizophrenia, Psychotic Disorders and Delusions, sponsored by Philipps University Marburg. Completed at 2 sites in Germany. Open to participants aged 16 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-03-05.

Sponsored by Philipps University Marburg · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
94
Allocation
Randomized
Ages
16 Years to 70 Years
Sex
All
01

Study summary

The aim of the present single-blind randomized-controlled therapy study is to assess the efficacy of a new form of Cognitive Behavioral Therapy for delusions with a focus on emotion regulation, improvement of self-esteem and sleep quality (CBTd-E).

Read the detailed description

Numerous meta-analyses have found Cognitive Behaviour Therapy for psychosis (CBTp) to be effective. The effect sizes that are achieved for positive symptoms in addition to antipsychotic treatment vary between small to medium. However, the effect sizes for changes in delusions are somewhat lower. Thus, it could prove beneficial to tailor CBTp interventions more precisely to the processes that are relevant to delusions. Empirically derived models of the formation and maintenance of delusions postulate an important role of cognitive biases, emotional factors and self-esteem. Additional studies have demonstrated the relevance of impaired sleep to delusions. Nevertheless, CBTp interventions that aim to change delusions tend to focus mainly on reasoning bias.

The results of several uncontrolled pilot studies that focused primarily at improving emotional factors, quality of sleep and self-esteem in patients with delusions indicate that changes in these factors have the potential to reduce delusions. However, in these studies the singular interventions were short and were not implemented into a broader therapy rational. It can thus be assumed that a combination of CBT-interventions within a broader therapy rational might have an even greater impact on delusions.

The aim of the present single-blind randomized-controlled therapy study is to assess the efficacy of a new form of Cognitive Behavioral Therapy for delusions with a focus on emotion regulation, improvement of self-esteem and sleep quality (CBTd-E) that will be applied in 25 individual sessions. Moreover, the study aims to test whether the efficacy of CBTd-E is mediated by the postulated processes. The main hypotheses are:

  1. Baseline differences: in comparison to healthy controls, patients with schizophrenia show more pronounced problems in emotion regulation, a reduced sleep quality and a lower and less stable self-esteem.
  2. Efficacy of CBTd-E: patients with acute delusions who receive CBTd-E show a more pronounced reduction of delusions (primary outcome), as well as a more pronounced reduction of positive symptoms, depression and general psychopathology, a stronger improvement in general and social functioning and will receive lower doses of antipsychotic medication (secondary outcomes) at post-treatment.
  3. Mediation: the effect of CBTd-E on change in delusions is mediated by a) improved emotional stability and ability to regulate one's own emotions, b) improved sleep quality, c) improved and more stable self-esteem.

In addition to questionnaires and interviews, behavioral paradigms, psychophysiological assessments and electronic diaries will be used to test the hypotheses. If we can demonstrate that CBTd-E reduces delusions, this would provide us with a more acceptable and feasible therapy for treating delusions.

02

Conditions studied

  • Schizophrenia
  • Psychotic Disorders
  • Delusions
  • Emotions
  • Self-esteem
  • Sleep

Keywords

  • Delusions
  • Schizophrenia
  • Cognitive Behavior Therapy
  • Emotion
  • Emotion regulation
  • self-esteem
  • sleep quality
  • Efficacy of change
03

In context

Schizophrenia

3,563 studies on the registry are indexed under Schizophrenia; 491 are open to participants now.

This study's enrollment of 94 is above the median of 71 across 2,944 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

Philipps University Marburg is the lead sponsor of 116 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Treatment Group:

Inclusion criteria

Inclusion Criteria:

  • Diagnosis of schizophrenia, schizoaffective disorder, delusional disorder ( diagnosis)
  • Delusions present in the last three months (score of at least three in three out of six PSYRATS scores)
  • problems in at least two out of three possible mediators: sleep problems (ISI sum score > 7), low self-esteem (score > 3in the BCSS negative self scale) and/or problems in emotion regulation (score in all items \< 4)
  • fluent in German language
  • agree to participate
  • estimated general intelligence of at least 70 in the German Mehrfachwahlwortschatztest (MWT-B)
  • no present suicidality

Exclusion criteria

Exclusion Criteria:

  • acute suicidal tendency
  • comorbid diagnosis of borderline personality disorder and/or substance use disorder in the last six month
  • taking of Benzodiazepines
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
94 participants (actual)

Study arms

  • Active comparator
    CBTd-E

    Experimental: emotion-oriented Cognitive Behavior Therapy focused on delusions for patients with schizophrenia-spectrum disorders and delusions. The therapeutical intervention follows a treatment-manual consisting of two modules. Patients work on two modules every week for 25 weeks in a row. Module I comprises psychoeducation on emotions, training radical acceptance of emotions and mindfulness, cognitive and behavioral strategies in order to change negative emotions and in order to foster positive emotions and suggestions for life-style changes (positive activities, sports, stress reduction). In the second module, the focus is on self-acceptance. Patients receive psychoeducation on self-acceptance and learn strategies in order to reduce negative self-schema and foster positive self-schema.

    Behavioral: emotion-oriented Cognitive Behavior Therapy

  • Placebo comparator
    Treatment as Usual

    Patients who are randomized and assigned to the Wait-list receive treatment as usual (regular visits to a physicist every third month and antipsychotic medication). After six month the waiting list patients receive the treatment specified above.

    Behavioral: emotion-oriented Cognitive Behavior Therapy

Interventions

  • Behavioralemotion-oriented Cognitive Behavior Therapy

    Emotion-oriented Cognitive Behavior Therapy with a focus on delusions: Aim of the intervention is to change factors that are involved in the formation and maintenance of delusions: emotional stability and regulation of negative emotions, sleep quality and self-esteem.

    Also known as: CBTd-E

06

What researchers measure

Primary outcomes

  1. Change in Psychotic Rating Scale (PSYRATS) delusions scale

    Assessment of delusion frequency, delusion distress, conviction and loss of quality of life due to the delusion

    Time frame: Change between pre-therapy and post-therapy assessment after six month

Secondary outcomes

  1. Change in Positive and Negative Syndrome Scale (PANSS)

    Assessment of positive, negative and general symptoms of schizophrenia

    Time frame: Change between pre-therapy and post-therapy assessment after six month

  2. Change in Calgary Depression Rating Scale for Schizophrenia (CDSS(

    Assessment of depressive symptoms in patients with schizophrenia

    Time frame: Change between pre-therapy and post-therapy assessment after six month

  3. Change in Role Functioning Scale (RFS)

    Assessment of social functioning

    Time frame: Change between pre-therapy and post-therapy assessment after six month

  4. Change in Peters et al. Delusions Inventory (PDI- R)

    Assessment of self-rated delusion frequency, conviction and distress.

    Time frame: Change between pre-therapy and post-therapy assessment after six month

Other outcomes

  1. Change in Emotion-regulation Questionnaire (ERQ)

    Questionnaire assesses the regular use of emotion regulation strategies

    Time frame: Change between pre-therapy and post-therapy assessment after six month

  2. Change in Emotion regulation inventory

    Questionnaire assesses the regular use of emotion regulation strategies

    Time frame: Change between pre-therapy and post-therapy assessment after six month

  3. Change in Paranoia assessed with Electronical mobile assessment

    Assessment of present emotions, emotion regulation strategies, present symptoms of psychosis, present delusions, self-esteem for six consecutive days (10 assessments per day) in daily life

    Time frame: Change between pre-therapy and post-therapy assessment after six month

  4. Change in Sleep quality as assessed with an Actiwatch

    Assessment of sleep-quality using an electronic bracelet for six consecutive days, sleep quality is assessed with movement detectors and light sensors

    Time frame: Change between pre-therapy and post-therapy assessment after six month

  5. Change in Emotion regulation quality as assessed experimental using International Affect Picture System Paradigm for the Assessment of emotion regulation (IAPS)

    Assessment of effectiveness of use of emotion regulation strategies after experimental induction of fear, assessment of heart rate and skin conduction

    Time frame: Change between pre-therapy and post-therapy assessment after six month

  6. Change in heart rate variability

    Assessment of heart rate variability with sensors during stress induction (reaction experiment) and during rest

    Time frame: Change between pre-therapy and post-therapy assessment after six month

  7. Change in Brief Core Schema Scale (BCSS)

    Assessment of positive and negative self-schemata and schemata on others

    Time frame: Change between pre-therapy and post-therapy assessment after six month

  8. Change in Insomnia Severity Index (ISI)

    The ISI assesses present sleep problems

    Time frame: Change between pre-therapy and post-therapy assessment after six month

  9. Change in Self-Compassion Scale (SCS)

    SCS assesses self-compassion and self-esteem

    Time frame: Change between pre-therapy and post-therapy assessment after six month

  10. Change in Self-perception of emotional competencies (SEK-27)

    Questionnaire assesses the regular use of emotion regulation strategies

    Time frame: Change between pre-therapy and post-therapy assessment after six month

07

Study locations

2 sites
  • University of Marburg, Faculty of Clinical Psychology and Psychotherapy
    Marburg, Hessen 35037, Germany
  • University of Hamburg, Faculty of Clinical Psychology and Psychotherapy
    Hamburg, 20146, Germany
08

References and documents

Publications

  • Kammerer MK, Mehl S, Ludwig L, Lincoln TM. Sleep and circadian rhythm disruption predict persecutory symptom severity in day-to-day life: A combined actigraphy and experience sampling study. J Abnorm Psychol. 2021 Jan;130(1):78-88. doi: 10.1037/abn0000645. Epub 2020 Nov 19. PubMed 33211503 ↗
  • Ludwig L, Mehl S, Krkovic K, Lincoln TM. Effectiveness of emotion regulation in daily life in individuals with psychosis and nonclinical controls-An experience-sampling study. J Abnorm Psychol. 2020 May;129(4):408-421. doi: 10.1037/abn0000505. Epub 2020 Feb 27. PubMed 32105124 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 5, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02787135
Collaborators
University of Hamburg-Eppendorf, Ruhr University of Bochum
Responsible party
Prof. Dr. Stephanie Mehl (Prof. Dr. rer. nat., Philipps University Marburg) — Principal investigator
First posted
Jun 1, 2016
Start date
May 1, 2016
Primary completion
Dec 31, 2019
Completion
Dec 31, 2019
Last update
Mar 5, 2020

Study contacts

Stephanie Mehl, Ph. D.
study chair · Philipps University Marburg
Tania M Lincoln, Ph. D.
study chair · University of Hamburg-Eppendorf
Tobias Teismann, Ph. D.
principal investigator · Ruhr University of Bochum

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion